Literature DB >> 8809474

Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up.

Z Liu1, L E Hultin, W G Cumberland, P Hultin, I Schmid, J L Matud, R Detels, J V Giorgi.   

Abstract

Relative fluorescence intensity measurements from a flow cytometer were used to evaluate expression of CD38 and HLA-DR antigens. These molecules are associated with cellular activation and are present at increased levels on the CD8+ lymphocytes of HIV-infected subjects. In the current study, the prognostic value of mean fluorescence intensity measurements of CD38 and HLA-DR on CD8+ cells was compared to results from our previous study in which we reported prognostic value for an elevated percentage of CD8+ cells that were positive for expression of the CD38 antigen (Giorgi et al.: JAIDS 6:904-912, 1993). Using the proportional hazards model, elevated mean fluorescence intensity of CD38 expression on CD8+ cells had prognostic value for development of AIDS that was almost identical to the prognostic value of the percentage of CD8+ cells that were positive for expression of CD38. This prognostic value was in addition to that provided by the patient's CD4+ cell measurement. To our knowledge, this is the first report that a measurement of fluorescence intensity can be used as a prognostic marker in an immunodeficiency disease. Efforts are needed to establish methods that will allow widespread application of this observation in the clinical management of HIV-infected subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809474     DOI: 10.1002/(SICI)1097-0320(19960315)26:1<1::AID-CYTO1>3.0.CO;2-L

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  35 in total

Review 1.  Monitoring patients with HIV disease.

Authors:  M Helbert; J Breuer
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.

Authors:  K S Froebel; G M Raab; C D'Alessandro; M P Armitage; K M MacKenzie; M Struthers; J M Whitelaw; S Yang
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

3.  Key Concepts in the Early Immunology of HIV-1 Infection.

Authors:  Basile Siewe; Alan Landay
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

4.  Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.

Authors:  J Ferbas; E S Daar; K Grovit-Ferbas; W J Lech; R Detels; J V Giorgi; A H Kaplan
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

5.  Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy.

Authors:  Edwin D Charlebois; Theodore D Ruel; Anne F Gasasira; Jane Achan; Frederick Kateera; Caroline Akello; Huyen Cao; Grant Dorsey; Philip J Rosenthal; Isaac Ssewanyana; Moses R Kamya; Diane V Havlir
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

6.  Dynamic quantification of antigen molecules with flow cytometry.

Authors:  A E Moskalensky; A V Chernyshev; M A Yurkin; V M Nekrasov; A A Polshchitsin; D R Parks; W A Moore; A Filatenkov; V P Maltsev; D Y Orlova
Journal:  J Immunol Methods       Date:  2015-02-14       Impact factor: 2.303

7.  Neural network-longitudinal assessment of the Electronic Anti-Retroviral THerapy (EARTH) cohort to follow response to HIV-treatment.

Authors:  George E Hatzakis; Moses Mathur; Louise Gilbert; George Panos; Ajay Wanchu; Atul K Patel; J K Maniar; Christos M Tsoukas
Journal:  AMIA Annu Symp Proc       Date:  2005

8.  Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Roger Detels
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

9.  Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection.

Authors:  S Zidovec Lepej; A Vince; O Dakovic Rode; A Remenar; T Jeren
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  Immunophenotypic alterations in acute and early HIV infection.

Authors:  Lena Al-Harthi; Sam MaWhinney; Elizabeth Connick; Robert T Schooley; Jeri E Forster; Constance Benson; Melanie Thompson; Franklyn Judson; Frank Palella; Alan Landay
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.